HIV-associated Lipodystrophy Syndrome is when there is a loss of fat in certain areas of the body caused by an infection with HIV. HIV, or the Human Immunodeficiency Virus, is a virus that compromises the immune system and causes other infections of invade the body. The cause of HIV-associated Lipodystrophy Syndrome is still being studied, but some sources say it is caused by the HIV infection others say it is caused by the anti-viral medications. Commonly, fat loss occurs in the face, arms, butt, and legs. Fat can also accumulate in areas such as the upper back, chest, and abdomen. HIV-associated Lipodystrophy Syndrome is treated with a medication that helps the production of growth hormones.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hiv-associated Lipodystrophy Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 2885 products for the study of Hiv-associated Lipodystrophy Syndrome that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.